What it does
MarketSurge by Investor's Business Daily combines stock charts, company fundamentals, proprietary ratings and screening lists. It is a paid research service for investors who want technical and business data in one workspace, with mobile access for following stocks away from a desktop.
MarketSurge places technical charts and company fundamentals in one research workspace. Its Growth 250 list and custom screens help narrow a research list; ratings add IBD's interpretation alongside the underlying earnings and price data. Chart styles include candlesticks and bars, with configurable studies and pattern recognition.
Several controls are useful to learn early. Find IBD studies such as the Earnings Line in the Studies window's IBD Proprietary section. The Wrench menu switches crosshair tracking on or off. Customize the fundamental columns in a data table, and use Refresh when you want a screen to generate a current list. Desktop chart annotations do not carry over to the mobile and tablet apps.
Subscription options
| Option | Published USD price | Billing detail |
|---|---|---|
| Introductory trial | $24.95 for 30 days | Then $149.95 per month |
| Monthly | $149.95 per month | Recurring monthly subscription |
| Annual | $1,499 per year | Annual billing |
The introductory period is paid. Membership includes the platform's premium features, and iOS and Android apps provide mobile charts and alerts. To cancel, use the subscription settings in My IBD or contact customer service. MarketSurge says it retains saved user data for six months after cancellation.
Strengths
- Combines configurable charts with company fundamentals and IBD screening lists
- Offers proprietary studies through a dedicated chart menu
- Provides iOS and Android access with alerts
Watch out for
- The introductory trial costs money and renews monthly unless canceled
- Desktop chart annotations do not appear in mobile and tablet apps
Best for
- Stock researchers combining technical and fundamental analysis
- IBD users building and revisiting stock screening lists
Sources
- MarketSurge research features and subscription options (Oct 27, 2026)
- MarketSurge platform controls and frequently asked questions (Oct 27, 2026)